In Brief: CompuMed
This article was originally published in The Gray Sheet
Executive Summary
CompuMed: Plans to commence clinical trials in the fourth quarter for its OsteoView 2000 digital system for osteoporosis and arthritis detection. The system incorporates "image processing and segmentation tools," as well as a "high resolution direct digital x-ray capture technology," CompuMed explains. The device, for which Manhattan Beach, California-based CompuMed will seek 510(k) market clearance, "is expected to be the first machine in the world to enable diagnosis of both osteoporosis and arthritis," the firm maintains...